TET2 and myelodysplastic syndrome: Patients with MDS harboring TET2 mutations exhibit phenotypic and functional defects in circulating NK cells, including increased DNA methylation, reduced expression of killer immunoglobulin-like receptors, and decreased cytotoxic protein expression [29].